Track XOMA Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

XOMA Corporation XOMAO · Stock Open XOMA Corporation in new tab

25.00 USD
P/E
24.98
EPS
1.00
Yield
8.38%
Safety Score
60
P/B
3.21
ROE
34.23
Beta
0.87
Loading chart...
Key Metrics
P/E24.98
EPS1.00
Book Value7.79
Price to Book3.21
Debt/Equity110.49
Growth
Revenue Growth-0.23%
Earnings Growth2.08%
Dividend
Dividend Yield8.38%
Annual dividends2.09 USD
Ex-Div. DateJuly 2, 2026
Payout12.30%

DCF Valuation

Tweak assumptions to recompute fair value for XOMA Corporation (XOMAO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

XOMA Corporation Logo XOMA Corporation Analysis (XOMAO)

United States Health Care Official Website Stock

Is XOMA Corporation a good investment? XOMA Corporation (XOMAO) is currently trading at 25.00 USD.

In terms of valuation, the stock trades at a P/E ratio of 24.98. This valuation is generally in line with the broader market.

For income investors, XOMA Corporation pays a dividend yield of 8.38%. With a payout ratio of 12%, the dividend appears sustainable.

Investor FAQ

Does XOMA Corporation pay a dividend?

Yes, it pays an annual dividend of 2.09 USD (8.38% yield).

What asset class is XOMA Corporation?

XOMA Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. As of July 14, 2026, XOMA Royalty Corporation operates as a subsidiary of Ligand Pharmaceuticals Incorporated.

Exchange Ticker
NMS (United States) XOMAO
Trades
Dividend Yield
8.38%
Annual Dividends
2.09USD
Next Ex. Div Date
July 2, 2026
Payout Ratio
12.30%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
2027
1.56 USD
July 15, 2027 (estimated) 0.5126
April 15, 2027 (estimated) 0.5234
Jan. 15, 2027 (estimated) 0.5237
2026
2.09 USD
Oct. 15, 2026 (estimated) 0.5236
July 14, 2026 0.5234
April 15, 2026 0.5234
Jan. 15, 2026 0.5234
2025
2.09 USD
Oct. 15, 2025 0.5234
July 15, 2025 0.5234
April 15, 2025 0.5234
Jan. 15, 2025 0.5234
2024
2.09 USD
Oct. 15, 2024 0.5234
July 15, 2024 0.5234
April 15, 2024 0.5234
Jan. 16, 2024 0.5234
2023
2.09 USD
Oct. 16, 2023 0.5234
July 17, 2023 0.5234
April 17, 2023 0.5234
Jan. 17, 2023 0.5230
2022
2.09 USD
Oct. 17, 2022 0.5230
July 15, 2022 0.5230
April 15, 2022 0.5234
Jan. 18, 2022 0.5230
2021
1.08 USD
Oct. 15, 2021 0.5230
July 15, 2021 0.5580
Upcoming Dividends
Name Payment Date Status Amount
XOMA Corporation Jul 14, 2026 0.52344 USD
XOMA Corporation Apr 15, 2026 0.52344 USD
XOMA Corporation Jan 15, 2026 0.52344 USD
XOMA Corporation Oct 15, 2025 0.52344 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion